Thomas Fuchss

This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignees: Altana Pharma Ag, Nycomed Gmbh. Active years: 2004-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Fuchss. Retrieved from https://idiyas.com/inventor/thomas-fuchss-ecugzjhz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6 (Patent Applications = 1)

Average Co-Inventor Count = 1.7

ph-index = 1

Forward Citations = 1(Granted Patents)

Location History:

Constance, DE (2004)
Radolfzell, DE (2008 - 2010)

Company Filing History:

Years Active: 2004-2010

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7790710 - Imidazopyridine derivatives useful as iNOS inhibitors (2010-09-07),

2. 7781453 - Aminopyridine-derivatives (2010-08-24),

3. 7329677 - Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors (2008-02-12),

4. 7317021 - Aminopyridine-derivatives as inductible no-synthase inhibitors (2008-01-08),

5. 6812349 - Process and intermediates for the preparation of imidazopyridines (2004-11-02),

6. 6716990 - Process and intermediates for the preparation of imidazopyridines (2004-04-06),

Title: The Innovative Contributions of Thomas Fuchss

Introduction

Thomas Fuchss is a notable inventor based in Radolfzell, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for specific enzymes. With a total of six patents to his name, Fuchss has established himself as a key figure in his area of expertise.

Latest Patents

Among his latest patents are the "Imidazopyridine derivatives useful as iNOS inhibitors." These compounds, defined by the formula (I) where R1, R11, and A have specific meanings, are recognized as novel and effective inhibitors of the enzyme iNOS. Another significant patent is for "Aminopyridine-derivatives," which also features a formula (I) with defined variables R1, R2, R3, and R4, showcasing their effectiveness as iNOS inhibitors.

Career Highlights

Fuchss has worked with prominent companies in the pharmaceutical industry, including Altana Pharma AG and Nycomed GmbH. His experience in these organizations has allowed him to contribute to the development of innovative medical solutions.

Collaborations

Throughout his career, Thomas Fuchss has collaborated with esteemed colleagues such as Wolf-Rüdiger Ulrich and Christian Scheufler. These partnerships have further enhanced his research and development efforts.

Conclusion

In summary, Thomas Fuchss is a distinguished inventor whose work in developing iNOS inhibitors has made a significant impact in the pharmaceutical field. His patents and collaborations reflect his commitment to innovation and excellence in research.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent pending: